These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1325 related articles for article (PubMed ID: 29131895)

  • 1. Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis.
    Brunström M; Carlberg B
    JAMA Intern Med; 2018 Jan; 178(1):28-36. PubMed ID: 29131895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure targets for hypertension in people with diabetes mellitus.
    Arguedas JA; Leiva V; Wright JM
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008277. PubMed ID: 24170669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
    Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
    Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
    Ettehad D; Emdin CA; Kiran A; Anderson SG; Callender T; Emberson J; Chalmers J; Rodgers A; Rahimi K
    Lancet; 2016 Mar; 387(10022):957-967. PubMed ID: 26724178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2014 Dec; 32(12):2285-95. PubMed ID: 25255397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2016 Apr; 34(4):613-22. PubMed ID: 26848994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intensive blood pressure lowering on mortality and cardiovascular and renal outcomes in type 2 diabetic patients: A meta-analysis.
    Wang J; Chen Y; Xu W; Lu N; Cao J; Yu S
    PLoS One; 2019; 14(4):e0215362. PubMed ID: 30978254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis.
    Bundy JD; Li C; Stuchlik P; Bu X; Kelly TN; Mills KT; He H; Chen J; Whelton PK; He J
    JAMA Cardiol; 2017 Jul; 2(7):775-781. PubMed ID: 28564682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
    Pinho-Gomes AC; Azevedo L; Copland E; Canoy D; Nazarzadeh M; Ramakrishnan R; Berge E; Sundström J; Kotecha D; Woodward M; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
    PLoS Med; 2021 Jun; 18(6):e1003599. PubMed ID: 34061831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
    Xie X; Atkins E; Lv J; Bennett A; Neal B; Ninomiya T; Woodward M; MacMahon S; Turnbull F; Hillis GS; Chalmers J; Mant J; Salam A; Rahimi K; Perkovic V; Rodgers A
    Lancet; 2016 Jan; 387(10017):435-43. PubMed ID: 26559744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.
    Emdin CA; Rahimi K; Neal B; Callender T; Perkovic V; Patel A
    JAMA; 2015 Feb; 313(6):603-15. PubMed ID: 25668264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.
    Blood Pressure Lowering Treatment Trialists' Collaboration
    Lancet; 2021 May; 397(10285):1625-1636. PubMed ID: 33933205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systolic Blood Pressure Control Targets to Prevent Major Cardiovascular Events and Death in Patients With Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.
    Yang Q; Zheng R; Wang S; Zhu J; Li M; Wang T; Zhao Z; Xu M; Lu J; Chen Y; Ning G; Wang W; Bi Y; Xu Y
    Hypertension; 2023 Aug; 80(8):1640-1653. PubMed ID: 37254768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension. 11. Effects of total cardiovascular risk and achieved blood pressure: overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 Nov; 35(11):2138-2149. PubMed ID: 28858983
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 67.